参考文献/References:
［1］SALEHI-RAD R，LI R，PAUL MK，et al.The biology of lung cancer:development of more effective methods for prevention，diagnosis，and treatment[J].Clinics in Chest Medicine，2020，41(1):25-38.
[2]WU FY，WANG L，ZHOU CC.Lung cancer in China:current and prospect[J].Current Opinion in Oncology，2021，33(1):40-46.
[3]王贤慧，刘丹丹.小细胞肺癌分子靶向治疗的研究进展[J].癌症进展，2021，19(16):1621-1624.
[4]吴琳，姚欢，王西歌，等.阳和汤治疗肺癌的临床应用与研究进展[J].现代中医药，2021，41(3):10-13.
[5]赵艳莉，李仁廷，吴召利.扶正祛痰方联合顺铂治疗非小细胞肺癌的实验研究[J].现代中医药，2018，38(4):102-105.[6]胡序，席孝忠.自拟扶正益气化痰方辅助治疗晚期非小细胞肺癌患者的效果及对免疫功能的影响[J].现代中医药，2021，41(4):95-98.[7]ZHUANG ZJ，CHEN QY，HUANG CH，et al.A comprehensive network pharmacology-based strategy to investigate multiple mechanisms of HeChan Tablet on lung cancer[J].Evidence-Based Complementary and Alternative Medicine:ECAM，2020，2020:7658342.[8]YI KY，ZHOU YN，ZHANG M，et al.The core mechanism of Yiqi Yangjing Decoction inhibiting nonsmall-cell lung cancer[J].Evidence-Based Complementary and Alternative Medicine:ECAM，2022，2022:2256671.[9]LI X，TANG YL，LIANG PC，et al.Luteolin inhibits A549 cells proliferation and migration by down-regulating androgen receptors[J].European Journal of Medical Research，2023，28(1):353.[10]WEI HB，ZHOU LH，ZHAO XJ，et al.Network-based pharmacological study on the mechanism of action of Buxue liqi Huatan Decoction in the treatment of lung cancer[J].Computational Intelligence and Neuroscience，2022，2022:3418687.[11]PAN JJ，YANG HK，ZHU LH，et al.Qingfei Jiedu Decoction inhibits PD-L1 expression in lung adenocarcinoma based on network pharmacology analysis，molecular docking and experimental verification[J].Frontiers in Pharmacology，2022，13:897966.[12]CHEN CY，KAO CL，LIU CM.The cancer prevention，anti-inflammatory and anti-oxidation of bioactive phytochemicals targeting the TLR4 signaling pathway[J].International Journal of Molecular Sciences，2018，19(9):2729.[13]KASALA ER，BODDULURU LN，BARUA CC，et al.Antioxidant and antitumor efficacy of Luteolin，a dietary flavone on benzo(a)pyrene-induced experimental lung carcinogenesis[J].Biomedecine & Pharmacotherapie，2016，82:568-577.[14]莫景颖，罗笑珊，张海怡，等.木犀草素抗肿瘤作用研究概况[J].亚太传统医药，2021，17(2):177-181.[15]周珊珊，柳金可，吴神佳，等.三种中药单体对人非小细胞肺癌A549、NCI-H460细胞株的增殖抑制作用研究[J].阜阳师范大学学报(自然科学版)，2023，40(1):27-33.[16]SONOKI H，TANIMAE A，ENDO S，et al.Kaempherol and luteolin decrease claudin-2 expression mediated by inhibition of STAT3 in lung adenocarcinoma A549 cells[J].Nutrients，2017，9(6):597.[17]YU Q，ZHANG MD，YING QD，et al.Decrease of AIM2 mediated by luteolin contributes to non-small cell lung cancer treatment[J].Cell Death & Disease，2019，10(3):218.[18]JIANG ZB，WANG WJ，XU C，et al.Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer[J].Cancer Letters，2021，515:36-48.[19]ZHANG M，WANG R，TIAN J，et al.Targeting LIMK1 with luteolin inhibits the growth of lung cancer in vitro and in vivo[J].Journal of Cellular and Molecular Medicine，2021，25(12):5560-5571.[20]JIANG ZQ，LI MH，QIN YM，et al.Luteolin inhibits tumorigenesis and induces apoptosis of non-small cell lung cancer cells via regulation of microRNA-34a-5p[J].International Journal of Molecular Sciences，2018，19(2):447.[21]何飞.木犀草素与其它中药活性成分协同抗肺癌的分子机制研究[D].北京:北京化工大学，2023.[22]杨朋，钱军，陈文飞，等.木犀草素对人非小细胞肺癌A549细胞凋亡及自噬的影响[J].中成药，2022，44(8):2667-2671.[23]WU B，XIONG J，ZHOU Y，et al.Luteolin enhances TRAIL sensitivity in non-small cell lung cancer cells through increasing DR5 expression and Drp1-mediated mitochondrial fission[J].Archives of Biochemistry and Biophysics，2020，692:108539.[24]ZHOU ML，SHEN SY，ZHAO X，et al.Luteoloside induces G0/G1 arrest and pro-death autophagy through the ROS-mediated AKT/mTOR/p70S6K signalling pathway in human non-small cell lung cancer cell lines[J].Biochemical and Biophysical Research Communications，2017，494(1/2):263-269.[25]陈庆，蔡兴东.自噬和凋亡在木犀草素诱导肺癌A549细胞死亡中的作用[J].中医临床研究，2021，13(26):19-22.[26]ZANOAGA O，BRAICU C，JURJ A，et al.Progress in research on the role of flavonoids in lung cancer[J].International Journal of Molecular Sciences，2019，20(17):4291.[27]LI CY，WANG Q，SHEN S，et al.HIF-1α/VEGF signaling-mediated epithelial-mesenchymal transition and angiogenesis is critically involved in anti-metastasis effect of luteolin in melanoma cells[J].Phytotherapy Research，2019，33(3):798-807.[28]ANS E，ZUAZO A，IRIGOYEN M，et al.Flavonoids inhibit hypoxia-induced vascular endothelial growth factor expression by a HIF-1 independent mechanism[J].Biochemical Pharmacology，2010，79(11):1600-1609.[29]任开明，周兆丽，石文君.木犀草素对人非小细胞肺癌A549细胞增殖、凋亡、侵袭及迁移能力的影响[J].解剖科学进展，2019，25(4):361-363，367.[30]NASO LG，MARTNEZ VR，Ferrer EG，et al.Antimetastatic effects of VOflavonoid complexes on A549 cell line[J].Journal of Trace Elements in Medicine and Biology:Organ of the Society for Minerals and Trace Elements (GMS)，2021，64:126690.[31]缪存静，陈俊杰，历星，等.木犀草素逆转由TGF-β1诱导的人肺癌细胞上皮-间充质转化的实验研究[J].中国病理生理杂志，2019，35(7):1163-1168.[32]阮君山，周欢，蒋宗胜，等.木犀草素调控非小细胞肺癌上皮间质转化的分子机制[J].医药导报，2018，37(1):20-26.[33]MASRAKSA W，TANASAWET S，HUTAMEKALIN P，et al.Luteolin attenuates migration and invasion of lung cancer cells via suppressing focal adhesion kinase and non-receptor tyrosine kinase signaling pathway[J].Nutrition Research and Practice，2020，14(2):127-133.[34]LIN HW，SHEN TJ，YANG NC，et al.Luteolin reduces aqueous extract PM2.5-induced metastatic activity in H460 lung cancer cells[J].International Journal of Medical Sciences，2022，19(10):1502-1509.[35]ZHANG J，ZHANG WH，MORISSEAU C，et al.Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase attenuated particulate matter 2.5 exposure mediated lung injury[J].Journal of Hazardous Materials，2023，458:131890.[36]LIN D，KUANG G，WAN JY，et al.Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression[J].Oncology Reports，2017，37(2):895-902.[37]ZAJＡCZKOWSKA R，KOCOT-KPSKA M，LEPPERT W，et al.Bone pain in cancer patients:mechanisms and current treatment[J].International Journal of Molecular Sciences，2019，20(23):6047.[38]ZHOU YS，CUI Y，ZHENG JX，et al.Luteolin relieves lung cancer-induced bone pain by inhibiting NLRP3 inflammasomes and glial activation in the spinal dorsal horn in mice[J].Phytomedicine:International Journal of Phytotherapy and Phytopharmacology，2022，96:153910.[39]BELTR M，PIN F，BALLAR R，et al.Mitochondrial dysfunction in cancer Cachexia:impact on muscle health and regeneration[J].Cells，2021，10(11):3150.[40]CHEN TJ，LI B，XU Y，et al.Luteolin reduces cancer-induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model[J].Oncology Reports，2018，40(2):1129-1137.[41]CHAMBERS CS，VIKTOROV J，RˇEHO RˇOV K，et al.Defying multidrug resistance!modulation of related transporters by flavonoids and flavonolignans[J].Journal of Agricultural and Food Chemistry，2020，68(7):1763-1779.[42]HELLWIG CT，REHM M.TRAIL signaling and synergy mechanisms used in TRAIL-based combination therapies[J].Molecular Cancer Therapeutics，2012，11(1):3-13.[43]LEE YJ，LIM T，HAN MS，et al.Anticancer effect of luteolin is mediated by downregulation of TAM receptor tyrosine kinases，but not interleukin-8，in non-small cell lung cancer cells[J].Oncology Reports，2017，37(2):1219-1226.[44]HUANG GD，LIU XN，JIANG T，et al.Luteolin overcomes acquired resistance to osimertinib in non-small cell lung cancer cells by targeting the HGF-MET-Akt pathway[J].American Journal of Cancer Research，2023，13(9):4145-4162.[45]洪专.木犀草素治疗EGF受体继发性突变的非小细胞肺癌的实验研究[D].南京:南京大学，2014.[46]OWUMI SE，NWOZO SO，ARUNSI UO，et al.Co-administration of Luteolin mitigated toxicity in rats’ lungs associated with doxorubicin treatment[J].Toxicology and Applied Pharmacology，2021，411:115380.[47]王允，张玉媛，陈雪，等.联合应用肌醇和木樨草素可选择性抑制肺腺癌A549细胞的生细胞的生长[J].南方医科大学学报，2018，38(11):1378-1383.[48]SLIKA H，MANSOUR H，WEHBE N，et al.Therapeutic potential of flavonoids in cancer:ROS-mediated mechanisms[J].Biomedecine & Pharmacotherapie，2022，146:112442.[49]魏海梁，曹妮，李京涛，等.基于miRNA-124探讨益脾养肝方对大鼠肝癌前病变影响的实验研究[J].陕西中医药大学学报，2020，43(5):60-65.[50]ZHENG H，ZHU XY，GONG EH，et al.Luteolin suppresses lung cancer progression through targeting the circ_0000190/miR-130a-3p/notch-1 signaling pathway[J].Journal of Chemotherapy，2023，35(4):330-342.[51]胡泽香，佟雷，耿艳萌，等.木犀草素的药理活性及其制剂研究进展[J].中医临床研究，2022，14(10):141-145.[52]IMAM SS，ALSHEHRI S，ALTAMIMI MA，et al.Formulation and evaluation of luteolin-loaded nanovesicles:in vitro physicochemical characterization and viability assessment[J].ACS Omega，2022，7(1):1048-1056.[53]肖建鹏，蒋俊，张振海，等.透明质酸包裹的木犀草素胶束制备及其对小鼠肺癌移植瘤的抑制作用[J].江苏大学学报(医学版)，2021，31(1):33-37.
相似文献/References:
[1]张亚密,任妍２,何伟３,等.基于隐结构模型的王希胜主任医师治疗肺癌的用药规律研究[J].现代中医药,2019,(05):004.[doi:10.13424/j.cnki.mtcm.2019.05.002]
Zhang Miya Ren Yan He Wei Yang Ning.Research on the Medication Rule of Chief Physician Wang Xisheng in the Treatment of Lung Cancer Based on Latent Structural Model[J].Modern Traditional Chinese Medicine,2019,(06):004.[doi:10.13424/j.cnki.mtcm.2019.05.002]
[2]赵恒昌１,赵敏越２.消岩汤辅助 ＴＰ化疗方案治疗肺癌的增效及抗毒副作用观察[J].现代中医药,2019,(05):071.[doi:10.13424/j.cnki.mtcm.2019.05.022]
[3]张涛１,刘改霞１,李耀辉２,等.中医药综合治疗晚期肺癌的研究进展[J].现代中医药,2019,(05):115.[doi:10.13424/j.cnki.mtcm.2019.05.034]
[4]任占良 侯俊明 任小朋 张 泳.穴位注射联合艾灸防治晚期肺癌化疗后胃肠道副反应的疗效观察[J].现代中医药,2018,(03):041.[doi:10．13424/j．cnki．mtcm．2018．03．014]
[5]黄伟 王希胜 *.王希胜教授运用健脾补肾法治疗肺癌临床经验[J].现代中医药,2018,(05):007.[doi:10．13424/j．cnki．mtcm．2018．05．003]
[6]韩英杰 侯俊明 张 泳 张卫锋 任占亮 邢明亮 任小朋.中医治疗结合快速康复外科在肺癌围手术期中的应用[J].现代中医药,2017,(05):070.[doi:10.13424/j.cnki.mtcm.2017.05.027]
[7]陈静 龙麟 李鹏 戎冬梅 李佩文 付文胜.基于中医传承辅助平台探索李佩文辨治非小细胞肺癌的用药规律[J].现代中医药,2020,(04):020.[doi:10.13424/j.cnki.mtcm.2020.04.005]
Chen Jing,Long Lin,Li Peng,et al.A Research on the Medication Rule of the Treatment of NSCLC by Li Peiwen Based on the TCMISS[J].Modern Traditional Chinese Medicine,2020,(06):020.[doi:10.13424/j.cnki.mtcm.2020.04.005]
[8]殷阿曼 韩琳 任小朋 张泳 任占良.中医护理干预对改善肺癌患者化疗后胃肠道不良反应的效果研究[J].现代中医药,2021,(02):106.[doi:10.13424/j.cnki.mtct.2021.02.023]
[9]吴琳 姚欢王西歌李艳赵美峰刘银环.阳和汤治疗肺癌的临床应用与研究进展[J].现代中医药,2021,(03):010.[doi:10.13424/j.cnki.mtcm.2021.03.003]
[10]张亦璐 焦丽静 许玲.基于真实世界回顾性分析中西医结合治疗对951例肺癌患者生存预后的影响[J].现代中医药,2022,1(04):119.[doi:10.13424/j.cnki.mtcm.2022.04.023]
ZHANG Yilu JIAO Lijing XU Ling.Retrospective Analysis of Effect of Integrated Traditional Chinese
and Western Medicine on Survival and Prognosis of 951 Patients
with Lung Cancer based on Real World[J].Modern Traditional Chinese Medicine,2022,1(06):119.[doi:10.13424/j.cnki.mtcm.2022.04.023]